文献速递焦虑、强迫与应激相关障碍

成人广泛性焦虑障碍的心理治疗:随机临床试验的系统综述与网络荟萃分析

Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
PubMed 文献 · JAMA Psychiatry · 2024-01-01

该系统综述与网络荟萃分析纳入65项随机临床试验、5048名成人广泛性焦虑障碍(GAD)患者,比较8种心理治疗与2种对照条件。结果显示,与常规治疗相比,第三波认知行为疗法(CBT)、CBT和放松疗法与GAD症状减轻相关;仅CBT在干预结束后3至12个月仍保持显著效果,提示CBT可能为GAD的一线心理治疗。

要点

  • 与常规治疗相比,第三波CBT、CBT和放松疗法与GAD症状短期减轻相关。
  • 仅CBT在干预结束后3至12个月仍与优于常规治疗的效果显著相关。
  • 所有心理治疗与常规治疗相比,全因脱落风险无显著差异。

核心结论

  • 基于急性和长期有效性证据,CBT可能代表GAD的一线心理治疗。
  • 第三波CBT和放松疗法与短期有效性相关,也可考虑提供。

研究设计与样本

  • 系统综述与网络荟萃分析,检索MEDLINE、Embase、PsycINFO和Cochrane对照试验注册库至2023年1月1日。
  • 纳入65项随机临床试验,比较8种心理治疗与彼此或2种对照条件,共5048名成人GAD患者。
  • 采用随机效应模型进行配对和网络荟萃分析,使用Cochrane偏倚风险工具第二版评估偏倚风险,使用CINeMA评定证据确定性。

主要发现

  • 与常规治疗相比,第三波CBT(SMD,-0.76;95%CI,-1.15至-0.36;确定性中等)与GAD症状减轻相关。
  • 与常规治疗相比,CBT(SMD,-0.74;95%CI,-1.09至-0.38;确定性中等)与GAD症状减轻相关。
  • 与常规治疗相比,放松疗法(SMD,-0.59;95%CI,-1.07至-0.11;确定性低)与GAD症状减轻相关。
  • 所有心理治疗与常规治疗相比,全因脱落相对风险无差异(例如CBT vs 常规治疗:RR,1.04;95%CI,0.64-1.67)。
  • 排除高偏倚风险研究后,放松疗法失去优于常规治疗的效果(SMD,-0.47;95%CI,-1.18至0.23)。

关键数值与推荐

  • 效应量为标准化均数差(SMD),可接受性为相对风险(RR)及95%CI。
  • 证据确定性:第三波CBT和CBT为中等,放松疗法为低。
  • 推荐:CBT可能为GAD一线心理治疗;第三波CBT和放松疗法可考虑用于短期效果。

临床怎么用

  • 临床可优先选择CBT作为成人GAD的一线心理治疗,因其兼具短期和长期有效性。
  • 第三波CBT和放松疗法可作为短期治疗选择,但放松疗法的证据确定性低且在高偏倚风险研究中效果不稳健。

局限性

  • 放松疗法在排除高偏倚风险研究后失去优于常规治疗的显著性。
  • 部分心理治疗的证据确定性为中至低,需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Generalized anxiety disorder (GAD) is one of the most common mental disorders in adults. Psychotherapies are among the most recommended treatments for GAD, but which should be considered as first-line treatment needs to be clarified. OBJECTIVE: To use a network meta-analysis to examine the short- and long-term associations of different psychotherapies with outcomes of effectiveness and acceptability in adults with GAD. DATA SOURCES: MEDLINE, Embase, PsycINFO, and the Cochrane Register of Controlled Trials were searched from database inception to January 1, 2023, to identify randomized clinical trials (RCTs) of psychotherapies for adults with GAD. STUDY SELECTION: RCTs comparing any type of psychotherapy against another or with a control condition for the treatment of adults (≥18 years, both sexes) with a primary diagnosis of GAD were eligible for inclusion. DATA EXTRACTION AND SYNTHESIS: This study followed Cochrane standards for extracting data and assessing data quality and used the PRISMA guideline for reporting. Risk of bias of individual studies was assessed using the second version of the Cochrane risk of bias tool, and the Confidence in Network Meta-Analysis was used to rate the certainty of evidence for meta-analytical results. MAIN OUTCOMES AND MEASURES: Eight psychotherapies were compared against one another and with 2 control conditions. Primary outcomes were severity of GAD symptoms and acceptability of the psychotherapies. Random-effects model pairwise and network meta-analyses were conducted. For effectiveness, standardized mean differences (SMDs) were pooled, and for acceptability, relative risks with 95% CIs were calculated. RESULTS: Data from 65 RCTs were included. Effect size estimates on data from 5048 participants (mean [SD], 70.9% [11.9%] women; mean [SD] age, 42.2 [12.5] years) suggested that third-wave cognitive behavior therapies (CBTs) (SMD, -0.76 [95% CI, -1.15 to -0.36]; certainty, moderate), CBT (SMD, -0.74 [95% CI, -1.09 to -0.38]; certainty, moderate), and relaxation therapy (SMD, -0.59 [95% CI, -1.07 to -0.11]; certainty, low) were associated with reduced GAD symptoms vs treatment as usual. Relative risks for all-cause discontinuation (indication of acceptability) signaled no differences compared with treatment as usual for all psychotherapies (eg, relative risk, 1.04 [95% CI, 0.64-1.67] for CBT vs treatment as usual). When excluding studies at high risk of bias, relaxation therapy lost its superiority over treatment as usual (SMD, -0.47; 95% CI, -1.18 to 0.23). When considering anxiety severity at 3 to 12 months after completion of the intervention, only CBT remained significantly associated with greater effectiveness than treatment as usual (SMD, -0.60; 95% CI, -0.99 to -0.21). CONCLUSIONS AND RELEVANCE: Given the evidence in this systematic review and network meta-analysis for its associations with both acute and long-term effectiveness, CBT may represent the first-line therapy of GAD. Third-wave CBTs and relaxation therapy were associated with short-term effectiveness and may also be offered.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Papola D, Miguel C, Mazzaglia M, et al. Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials. JAMA Psychiatry. 2024. PMID: 37851421. doi:10.1001/jamapsychiatry.2023.3971

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。